The United States and Canada have one of the largest economic partnerships in the world, and share the world’s largest international border. When COVID-19 hit in early 2020, that border was closed to all nonessential traffic. As more people on…
By Benedict Moran
The U.S. has also been under mounting pressure in recent weeks to share more of its vaccine supply with the world, as countries like India experience devastating surges of the virus.
By Zeke Miller, Associated Press
The outbreak in India adds to the pressure on President Joe Biden to provide vaccines to other countries. Biden has said the U.S. won’t begin doing so until it has enough supplies at home.
By Associated Press
In our news wrap Wednesday, the CDC says a highly contagious virus variant first found in Britain has now become the most common strain in the U.S., the Biden administration announced it’s resuming aid to Palestinians, at least 144 people…
The European Medicines Agency said a very rare side effect of the AstraZeneca COVID-19 vaccine is "unusual blood clots with low blood platelets." That's a blow to low- and middle-income countries because the vaccine is inexpensive, easier to transport and…
By Maria Cheng, Danica Kirka, Jill Lawless, Associated Press
Wednesday's recommendation came as regulators both in the U.K. and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people.
By Nick Schifrin, Layla Quran, Ali Rogin
Much of continental Europe is suffering through a third and brutal wave of COVID-19. Making matters worse, the drive to vaccinate throughout the European Union is faltering badly. Coupled with recent concerns about the AstraZeneca vaccine, the EU is running…
By Lauran Neergaard, Associated Press
AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its U.S. study, the latest in an extraordinary public dispute with American officials.
By Associated Press
Results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data, American federal health officials said early Tuesday.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.